Completed PHASE4 INTERVENTIONAL 2-arm NCT00852826

Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy

Value of a Hemostatic and Sealing Agent for Preventing Seroma After Axillary Lymphadenectomy

Sponsor: Hospital Universitario Virgen de la Arrixaca

Conditions Seroma

Interventions Collagen sponge coated with human coagulation factors Standard axillary lymphadenectomy

Updated 4 times since 2017 Last updated: Feb 26, 2009 Started: Jan 31, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Seroma, this trial is completed. The trial is conducted by Hospital Universitario Virgen de la Arrixaca and has accumulated 4 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario Virgen de la Arrixaca

Data source: Hospital Universitario Virgen de la Arrixaca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Murcia, Spain